RCEL - Avita Medical Ltd
Avita Medical Ltd Logo

RCEL - Avita Medical Ltd

https://avitamedical.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
Bearish
Securities Fraud Investigation Into AVITA Medical, Inc. ( RCEL ) Continues - Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - AVITA Medical ( NASDAQ:RCEL )
Benzinga • 1 week, 4 days ago • score: -0.24
LOS ANGELES, Sept. 03, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz continues its investigation of AVITA Medical, Inc. ( "Avita" or the "Company" ) RCEL on behalf of investors concerning the Company's possible violations of federal securities laws.
AI Tools
Key Metrics
Trend: Downtrend
As of 2025-09-10 (Snapshot)

AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom. The company is headquartered in Valencia, California.

52W High
$14.16
52W Low
$3.60
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.58
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
4.82
EV/EBITDA (<8 favorable)
-6.17
EV/Revenue (<3 favorable)
1.92
P/S (TTM) (<3 favorable)
1.54
P/B (<3 favorable)
11.77
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
0.91%
Institutions (25–75% balanced)
29.13%
Shares Outstanding
27,018,900
Float
26,034,900
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
74,884,000
Gross Profit (TTM)
63,111,000
EPS (TTM)
-1.97
Profit Margin (>10% good)
-0.69%
Operating Margin (TTM) (higher better)
-0.61%
ROE (TTM) (>15% strong)
-9.36%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.21
Momentum
Bearish momentum
Value
-0.2832
Previous
-0.3306
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025